Fumarate Hydratase Deficient Renal Cell Carcinoma

Explore clinical trials studying Fumarate Hydratase Deficient Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Fumarate Hydratase Deficient Renal Cell Carcinoma trial results

Completed

NCT04068831

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States

Active, Not Recruiting

NCT03635892

Conditions: Adenocarcinoma, Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Carcinoma, +20 more
Locations: Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen Montvale, New Jersey, United States

Memorial Sloan Kettering Commack Commack, New York, United States